(Q43525317)
Statements
1 reference
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanoma (English)
1 reference
J F Grippo
W Zhang
D Heinzmann
K H Yang
J Wong
A K Joe
P Munster
1 November 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference